Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

CD146 protein as a marker to predict postoperative liver metastasis in colorectal cancer.

Tian B, Zhang Y, Li N.

Cancer Biother Radiopharm. 2013 Jul-Aug;28(6):466-70. doi: 10.1089/cbr.2012.1426. Epub 2013 Jun 8.

PMID:
23745687
2.

Clinical implications of AEG-1 in liver metastasis of colorectal cancer.

Jiang T, Zhu A, Zhu Y, Piao D.

Med Oncol. 2012 Dec;29(4):2858-63. doi: 10.1007/s12032-012-0186-z. Epub 2012 Feb 16.

PMID:
22351252
3.

Nanog: a potential biomarker for liver metastasis of colorectal cancer.

Xu F, Dai C, Zhang R, Zhao Y, Peng S, Jia C.

Dig Dis Sci. 2012 Sep;57(9):2340-6. doi: 10.1007/s10620-012-2182-8. Epub 2012 May 6.

PMID:
22562535
4.

Stem cell gene Girdin: a potential early liver metastasis predictor of colorectal cancer.

Liu C, Xue H, Lu Y, Chi B.

Mol Biol Rep. 2012 Sep;39(9):8717-22. doi: 10.1007/s11033-012-1731-8. Epub 2012 Jun 20.

PMID:
22714912
5.

CXCR4 as a novel predictive biomarker for metastasis and poor prognosis in colorectal cancer.

Gao Y, Li C, Nie M, Lu Y, Lin S, Yuan P, Sun X.

Tumour Biol. 2014 May;35(5):4171-5. doi: 10.1007/s13277-013-1545-x. Epub 2014 Jan 7.

PMID:
24395653
6.

Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.

Zong Z, Zhou T, Rao L, Jiang Z, Li Y, Hou Z, Yang B, Han F, Chen S.

Cancer Med. 2016 Apr;5(4):623-30. doi: 10.1002/cam4.624. Epub 2016 Jan 18.

7.

Immunohistochemically detected high expression of matrix metalloproteinase-2 as predictor of poor prognosis in Duke's B colon cancer.

Sundov Z, Tomić S, Vilović K, Kunac N, Kalebić M, Bezić J.

Croat Med J. 2008 Oct;49(5):636-42.

8.

Clinical implications of periostin in the liver metastasis of colorectal cancer.

Wu G, Wang X, Zhang X.

Cancer Biother Radiopharm. 2013 May;28(4):298-302. doi: 10.1089/cbr.2012.1374. Epub 2013 Jan 24.

PMID:
23347152
9.

Aberrant expression of sphingosine-1-phosphate receptor 1 correlates with metachronous liver metastasis and poor prognosis in colorectal cancer.

Lin Q, Wei Y, Zhong Y, Zhu D, Ren L, Xu P, Zheng P, Feng Q, Ji M, Lv M, Liang C, Xu J.

Tumour Biol. 2014 Oct;35(10):9743-50. doi: 10.1007/s13277-014-2267-4. Epub 2014 Jun 28.

PMID:
24972972
10.

Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.

Hatate K, Yamashita K, Hirai K, Kumamoto H, Sato T, Ozawa H, Nakamura T, Onozato W, Kokuba Y, Ihara A, Watanabe M.

Oncol Rep. 2008 Oct;20(4):737-43.

PMID:
18813812
11.

Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.

Nasif WA, Lotfy M, El-Sayed IH, El-Kenawy Ael-M, El-Shahat M, El-Hak NG.

Med Oncol. 2006;23(2):237-44.

PMID:
16720924
12.

Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.

Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI.

Anticancer Res. 2001 Jan-Feb;21(1A):253-9.

PMID:
11299743
13.

[Evaluation of cyclooxygenase-2 in the prediction of liver metastasis of colorectal carcinoma].

Lu XY, Xu JM, Zhong YS, Ren L, Lai YH, Qin XY.

Zhonghua Wai Ke Za Zhi. 2007 Jan 1;45(1):54-7. Chinese.

PMID:
17403293
14.

The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.

Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.

J Pathol. 2003 Jun;200(2):183-94.

PMID:
12754739
15.

Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.

Wei JL, Fu ZX, Fang M, Guo JB, Zhao QN, Lu WD, Zhou QY.

Oncol Rep. 2015 Mar;33(3):1349-57. doi: 10.3892/or.2014.3701. Epub 2014 Dec 30.

PMID:
25572852
16.

Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.

Furudoi A, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F.

Oncology. 2001;60(2):162-9.

PMID:
11244332
17.

Expression of COX-2 and HER-2 in colorectal cancer and their correlation.

Wu QB, Sun GP.

World J Gastroenterol. 2015 May 28;21(20):6206-14. doi: 10.3748/wjg.v21.i20.6206.

18.

Multivariate analysis of molecular indicators for postoperative liver metastasis in colorectal cancer cases.

Qian LY, Li P, Li XR, Chen DJ, Zhu SH.

Asian Pac J Cancer Prev. 2012;13(8):3967-71.

19.

The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.

Tamagawa H, Oshima T, Shiozawa M, Morinaga S, Nakamura Y, Yoshihara M, Sakuma Y, Kameda Y, Akaike M, Masuda M, Imada T, Miyagi Y.

Oncol Rep. 2012 Mar;27(3):637-42. doi: 10.3892/or.2011.1547. Epub 2011 Nov 10.

PMID:
22076537
20.

[Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].

Zhao GP, Zhou ZG, Lei WZ, Wang C, Zheng XL, Zheng YC.

Zhonghua Wei Chang Wai Ke Za Zhi. 2008 Sep;11(5):487-91. Chinese.

PMID:
18803057

Supplemental Content

Support Center